Technical Analysis for ENLV - Enlivex Therapeutics Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Reached Oversold | Weakness | -0.70% | |
Wide Bands | Range Expansion | -0.70% | |
Down 3 Days in a Row | Weakness | -0.70% | |
Down 4 Days in a Row | Weakness | -0.70% | |
Down 5 Days in a Row | Weakness | -0.70% | |
Oversold Stochastic | Weakness | -0.70% | |
20 DMA Resistance | Bearish | -2.76% | |
Down 3 Days in a Row | Weakness | -2.76% | |
Down 4 Days in a Row | Weakness | -2.76% | |
Down 5 Days in a Row | Weakness | -2.76% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 1 hour ago |
Possible NR7 | about 3 hours ago |
Possible Inside Day | about 3 hours ago |
60 Minute Opening Range Breakdown | about 5 hours ago |
Down 2 % | about 5 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/24/2024
Enlivex is a clinical stage immunotherapy company, developing an allogeneic drug pipeline for immune system rebalancing. Immune system rebalancing is critical for the treatment of life-threatening immune and inflammatory conditions which involve hyper-expression of cytokines (Cytokine Release Syndrome) and for which there are no approved treatments (unmet medical needs), as well as solid tumors immune-checkpoint rebalancing.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Immunology Solid Tumors Immune System Immunotherapy Cancer Treatment Tumor Virotherapy Coronavirus Cytokine Inflammatory Conditions
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.59 |
52 Week Low | 1.15 |
Average Volume | 208,239 |
200-Day Moving Average | 2.36 |
50-Day Moving Average | 2.72 |
20-Day Moving Average | 1.50 |
10-Day Moving Average | 1.53 |
Average True Range | 0.21 |
RSI (14) | 31.97 |
ADX | 29.07 |
+DI | 16.93 |
-DI | 29.63 |
Chandelier Exit (Long, 3 ATRs) | 1.22 |
Chandelier Exit (Short, 3 ATRs) | 1.85 |
Upper Bollinger Bands | 1.72 |
Lower Bollinger Band | 1.27 |
Percent B (%b) | 0.33 |
BandWidth | 30.10 |
MACD Line | -0.31 |
MACD Signal Line | -0.37 |
MACD Histogram | 0.0645 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.59 | ||||
Resistance 3 (R3) | 1.59 | 1.54 | 1.56 | ||
Resistance 2 (R2) | 1.54 | 1.49 | 1.54 | 1.55 | |
Resistance 1 (R1) | 1.48 | 1.47 | 1.45 | 1.48 | 1.54 |
Pivot Point | 1.42 | 1.42 | 1.41 | 1.42 | 1.42 |
Support 1 (S1) | 1.36 | 1.38 | 1.34 | 1.36 | 1.30 |
Support 2 (S2) | 1.31 | 1.35 | 1.31 | 1.29 | |
Support 3 (S3) | 1.25 | 1.31 | 1.28 | ||
Support 4 (S4) | 1.25 |